NBY News and Press, NovaBay Pharmaceuticals Inc. From 05/09/24

2024-05-09 16:11:26 ET More on NovaBay NovaBay Pharmaceuticals, Inc. (NBY) Q4 2023 Earnings Call Transcript NovaBay Pharmaceuticals receives NYSE notice for compliance NovaBay Pharmaceuticals show 13% rise in eyecare and wound care segment - prelim report See...

Net product sales increased 13% over the prior year driven by higher sales of Avenova ® -branded products through OTC channels and branded wound care products Sales and marketing expenses declined 15% reflecting continued digital marketing optimization Ordered product sal...

Ordered product sales of Avenova ® -branded products on Amazon.com set back-to-back records in March and April 2024 Enhanced marketing program provides potential for additional growth in the U.S. dry eye disease treatment market projected to reach nearly $5 billion by 2030 ...

MONTREAL, May 07, 2024 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is proud to announce that, following re-sampling of historic Vior drill holes from the Foothills Project, assay results confirm the presence of phospha...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three months ended March 31, 2024 after market close on Thursday, May 9, 2024 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time....

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTRÉAL, April 30, 2024 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“ NioBay ” or the “ Company ”) (TSX-V: NBY) (OTCQB: NBYCF) is pleased to announce...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wound care products, announces a new and enhanced marketing program that includes text message communications (SMS) and targeted email programs aimed at enhancing the...

2024-04-22 01:43:28 ET More on NovaBay NovaBay Pharmaceuticals show 13% rise in eyecare and wound care segment - prelim report Seeking Alpha’s Quant Rating on NovaBay Historical earnings data for NovaBay Read the full article on Seeking Alpha F...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces that on April 18, 2024 it received a notice from the NYSE American LLC stating that the Company is below compliance with the NYSE American continued listing standards set forth in Sections 1003(a)(ii) and (iii) of the NYSE...

2024-04-17 07:23:47 ET More on NovaBay Seeking Alpha’s Quant Rating on NovaBay Historical earnings data for NovaBay Financial information for NovaBay Read the full article on Seeking Alpha For further details see: NovaBay Pharmaceuticals sh...